Michael C. Mulica - 09 Feb 2026 Form 4 Insider Report for DNA X, Inc. (SONM)

Role: Acting CEO, Director
Signature: /s/ Clay Crolius, by power of attorney
Issuer symbol: SONM
Transactions as of: 09 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 10 Feb 2026, 20:53:30 UTC
Previous filing: 25 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MULICA MICHAEL C	Acting CEO, Director	C/O DNA X, INC., 4445 EASTGATE MALL, SUITE 200, SAN DIEGO	/s/ Clay Crolius, by power of attorney	10 Feb 2026	0001211437

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SONM	Common Stock	Award	$0	+50,000	+1228%	$0.000000	54,071	09 Feb 2026	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units that vest in equal monthly installments over a one-year period following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock.
F2	Consists of (i) 4,071 shares of common stock and (ii) 50,000 unvested restricted stock units.
F3	The number of securities reported herein reflects the effects of a 1-for-18 reverse stock split effected by the Issuer on October 27, 2025, which was exempt from reporting pursuant to Rule 16a-9.